ReviewJournal of the American Heart Association2020
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the
Review in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.Journal of the American College of Cardiology · 2022Guideline
- Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis.Scientific reports · 2021Pooled it
- ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19.International journal of molecular sciences · 2024Article
- Pulmonary hypertension predicts higher mortality in patients admitted with severe COVID-19 infection.SAGE open medicine · 2023Article
- 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.Circulation. Cardiovascular quality and outcomes · 2022Review
- Role of Neuroimmune Interactions in COVID-19-related Cardiovascular Damage.Current medical science · 2022Review
- Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients.International journal of cardiology. Heart & vasculature · 2022Article
- Diversity in modern heart failure trials: Where are we, and where are we going.International journal of cardiology · 2022Review
- Postdischarge Evaluation for Individuals Hospitalized with COVID-19.Southern medical journal · 2022Article
- Experimental Technologies in the Diagnosis and Treatment of COVID-19 in Patients with Comorbidities.Journal of healthcare informatics research · 2022Review
- A Case Series of Diverse Cardiac Abnormalities in Collegiate Athlete with COVID-19: Role for Multimodality Imaging.Case reports in cardiology · 2022Article
- Drug repurposing against coronavirus disease 2019 (COVID-19): A review.Journal of pharmaceutical analysis · 2021Review
- The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring.Journal of clinical medicine · 2021Article
- Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19.Journal of cardiovascular development and disease · 2021Article
- Resuming professional football (soccer) during the COVID-19 pandemic in a country with high infection rates: a prospective cohort study.British journal of sports medicine · 2021Article
- Maternal medicine in the COVID era.Best practice & research. Clinical obstetrics & gynaecology · 2021Review
- Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era.Current cardiology reports · 2021Review
- The prognostic role of cardiac troponin in hospitalized COVID-19 patients.Atherosclerosis · 2021Article
- COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans.Scientific reports · 2021Article
- The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2020.Journal of cardiothoracic and vascular anesthesia · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Coronavirus Disease 2019 (COVID-19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.